PI: Nadia Fairbairn (BC Centre on Substance Use, BC)

Leadership Group: Bernard Le Foll (CAMH, ON); Christy Sutherland (Portland Hotel Society, BC); Jeffrey Turnbull (Ottawa Inner City Health, ON); Karine Meador & Michael Trew (Alberta Health Services, AB); Marie-Ève Goyer (University of Montréal, QC); Michel Perreault (McGill University, QC)

Objectives
The purpose of this thematic area is to facilitate and support the successful delivery of injectable opioid agonist treatment (iOAT) in Canada through educational resources, development of best practices and recommendations, and monitoring and evaluation.

Project Components

National iOAT Guideline

A national committee of experts published two complementary documents (Clinical Guideline and Operational Guidance), along with a summary article in CMAJ and a podcast.

Operational Guidance

Clinical Guidance

Environmental Scan of iOAT Services

The working group completed an environmental scan of all iOAT services in Canada and presented the results at the CPDD conference in June 2019 and submitted an academic article.

External Resources

Clinical Guideline for Prescribers

These guidelines provide clinical guidance to prescribers so that they can help patients reduce their risk and facilitate, where possible, social distancing and self-isolation in an effort to reduce and prevent the spread of COVID-19.

Guides de Pratique Clinique

Ces guides servent à fournir des conseils cliniques aux prescripteurs afin qu’ils puissent aider les patients à réduire les risques qu’ils encourent et faciliter, dans la mesure du possible, la distanciation sociale et l’auto-isolement dans le but de réduire et de prévenir la propagation de la COVID-19.

Addictions and Mental Health Ontario (AMHO)

AMHO received funding from Health Canada’s Substance Use and Addictions Program (SUAP) to lead a project on Planning for the Appropriate Use of Prescription Heroin.

This project aimed to assist provincial governments and health authorities in determining whether supervised iOAT programs should be expanded in Ontario for persons with severe opioid dependence. In addition, the project aimed to support the implementation of programs where appropriate by documenting system level processes, including training, and regulatory requirements that are necessary for successful implementation in Ontario and that reflect clinical and operational standards.

See more information about the project here

COMING SOON: National Community of Practice

Connect and engage a national group of healthcare providers and service delivery leaders to create a virtual, online community with the goal of sharing success stories and challenges, sharing resources, and participating in educational activities.